The Rise and Fall of EpidemicNeisseria meningitidisSerogroup W135 Meningitis in Burkina Faso, 2002–2005
Open Access
- 1 October 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (7) , 817-822
- https://doi.org/10.1086/507339
Abstract
Background. During the period 2001–2002, Burkina Faso reported its first meningitis epidemic due to Neisseria meningitidis (Nm) serogroup W135, prompting concerns that this serogroup would persist as a cause of epidemic disease. Methods. During the period 2002–2005, hospital- and population-based surveillances were conducted in 3 districts in Burkina Faso. Etiology was determined by culture, polymerase chain reaction (PCR), and latex agglutination. Reference laboratories determined phenotype and genotype. Results. of 2004 subjects who received a lumbar puncture, 265 were identified as having Nm, including 93 who had Nm serogroup A (NmA) and 146 who had Nm serogroup W135 (NmW135). Over the study period, the proportion of cases due to NmW135 decreased by >75%, primarily because of decreased occurrence among young children and in a single district. During peak epidemic months, the annualized incidence of NmW135 decreased from 146 cases to Conclusions. For unknown reasons, serogroup W135 achieved epidemic status, primarily among young children, and then largely disappeared over a short time period. The continued circulation of multiple strains with epidemic potential emphasizes the need for ongoing surveillance and the potential benefit of vaccines that are protective across serogroups.Keywords
This publication has 21 references indexed in Scilit:
- Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complexMicrobes and Infection, 2006
- The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina FasoMicrobes and Infection, 2005
- Bacterial Meningitis in Burkina Faso: Surveillance Using Field-Based Polymerase Chain Reaction TestingClinical Infectious Diseases, 2005
- Continuing Diversification of Neisseria meningitidis W135 as a Primary Cause of Meningococcal Disease after Emergence of the Serogroup in 2000Journal of Clinical Microbiology, 2004
- First Report of Capsule Replacement among Electrophoretic Type 37 Neisseria meningitidis Strains in ItalyJournal of Clinical Microbiology, 2003
- Outbreaks of serogroup X meningococcal meningitis in Niger 1995–2000Tropical Medicine & International Health, 2003
- Neisseria meningitidis Serogroups W135 and A Were Equally Prevalent among Meningitis Cases Occurring at the End of the 2001 Epidemics in Burkina Faso and NigerJournal of Clinical Microbiology, 2002
- Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganismsProceedings of the National Academy of Sciences, 1998
- Outer membrane protein serosubtyping ofNeisseria meningitidisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of SerotypesClinical Infectious Diseases, 1985